跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,587 条关于
“NASH cirrhosis”
全部
4,587
临床试验
3,854
药物
53
机构
10
资讯
670
去年
Madrigal Pharmaceuticals Reports Strong Rezdiffra Launch and Advancement of NASH Cirrhosis Study
2年前
Madrigal's Resmetirom Nears Full Approval for NASH Cirrhosis Treatment Following Phase 3 Enrollment Completion
去年
Madrigal Pharmaceuticals Reports Strong Rezdiffra Launch and Clinical Progress in NASH/MASH
去年
Madrigal Pharmaceuticals Reports Positive Q3 2024 Results and Advances NASH/MASH Programs
去年
Madrigal Pharmaceuticals Reports Strong Rezdiffra Launch and Clinical Progress in NASH/MASH
2年前
FDA Approves Rezdiffra (Resmetirom) as First Treatment for NASH with Liver Fibrosis
9个月前
Galectin Therapeutics Receives FDA Feedback on Belapectin MASH Cirrhosis Program, Secures $10 Million Financing
去年
Madrigal's Resmetirom Shows Promise in NASH Treatment Where Others Have Failed
去年
Madrigal's Rezdiffra Shows Promise in MASH Cirrhosis with Two-Year Data
去年
Resmetirom Shows Promise in Treating MASLD/MASH: A Comprehensive Review of Clinical Trials
第 1 页,共 67 页
上一页
下一页